Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2002;106:763-765
doi: 10.1161/01.CIR.0000025707.19008.0E
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Grayburn, P. A.
Right arrow Articles by Eichhorn, E. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Grayburn, P. A.
Right arrow Articles by Eichhorn, E. J.
Related Collections
Right arrow Valvular heart disease
Right arrow CV surgery: valvular disease

(Circulation. 2002;106:763.)
© 2002 American Heart Association, Inc.


Editorial

Dobutamine Challenge for Low-Gradient Aortic Stenosis

Paul A. Grayburn, MD; Eric J. Eichhorn, MD

From the Department of Internal Medicine, Division of Cardiology, VA Medical Center, and the University of Texas Southwestern Medical Center, Dallas, Tex.

Correspondence to Paul A. Grayburn, MD, Cardiology (111A), VA Medical Center, 4500 S Lancaster Rd, Dallas, TX 75216. E-mail paul.grayburn@ utsouthwestern.edu


Key Words: Editorials • stenosis • cardiomyopathy • inotropic agents • hemodynamics


An extract of the first 250 words of the full text is provided, because this article has no abstract.
 

In adults with valvular aortic stenosis (AS), valve replacement is recommended in the presence of symptoms and severely reduced aortic valve area (AVA).1 In such patients, valve replacement improves symptoms and survival, even in the setting of left ventricular (LV) dysfunction. LV dysfunction in severe AS is usually due to afterload mismatch; valve replacement relieves the afterload excess imposed by the stenotic valve and improves LV performance. 2 However, a subset of patients with " severe" AS, LV dysfunction, and low-transvalvular gradient has been reported to have a relatively high operative mortality and poor prognosis.2–4 This clinical scenario has been termed "low-flow, low-gradient AS." Accurate assessment of AVA in such patients is difficult because (1) calculated AVA is directly proportional to forward stroke volume, and (2) the Gorlin constant varies at low-flow states. 5–7 Some patients with low-flow, low-gradient AS have a reduced AVA as a result of inadequate forward stroke volume rather than anatomic stenosis, a situation analogous to reduced anterior mitral leaflet excursion in dilated cardiomyopathy where there is not enough forward flow to fully open the valve. For example, Cannon et al 8 showed that some patients with low-gradient AS were found to have only mild AS at surgery despite a Gorlin AVA indicating critical AS. Obviously, surgical therapy is unlikely to benefit such patients because their primary pathology is a cardiomyopathy. On the other hand, patients with severe anatomic AS may benefit from valve replacement despite the increased operative risk associated with a low-flow, low-gradient hemodynamic state. The recent . . . [Full Text of this Article]




This article has been cited by other articles:


Home page
Eur Heart J SupplHome page
K. Wachtell
Left ventricular systolic performance in asymptomatic aortic stenosis
Eur. Heart J. Suppl., July 1, 2008; 10(suppl_E): E16 - E22.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
J.-L. Monin, M. Monchi, M. E.W. Kirsch, H. Petit-Eisenmann, S. Baleynaud, C. Chauvel, D. Metz, C. Adams, J.-P. Quere, P. Gueret, et al.
Low-gradient aortic stenosis: impact of prosthesis-patient mismatch on survival
Eur. Heart J., November 1, 2007; 28(21): 2620 - 2626.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
B. A. Carabello
Aortic Stenosis: Two Steps Forward, One Step Back
Circulation, June 5, 2007; 115(22): 2799 - 2800.
[Full Text] [PDF]


Home page
HeartHome page
L. A Pierard and P. Lancellotti
Stress testing in valve disease
Heart, June 1, 2007; 93(6): 766 - 772.
[Full Text] [PDF]


Home page
CirculationHome page
R. A. Lange and L. D. Hillis
Dobutamine Stress Echocardiography in Patients With Low-Gradient Aortic Stenosis
Circulation, April 11, 2006; 113(14): 1718 - 1720.
[Full Text] [PDF]


Home page
CirculationHome page
P. A. Grayburn
Assessment of Low-Gradient Aortic Stenosis With Dobutamine
Circulation, February 7, 2006; 113(5): 604 - 606.
[Full Text] [PDF]


Home page
CirculationHome page
C. Blais, I. G. Burwash, G. Mundigler, J. G. Dumesnil, N. Loho, F. Rader, H. Baumgartner, R. S. Beanlands, B. Chayer, L. Kadem, et al.
Projected Valve Area at Normal Flow Rate Improves the Assessment of Stenosis Severity in Patients With Low-Flow, Low-Gradient Aortic Stenosis: The Multicenter TOPAS (Truly or Pseudo-Severe Aortic Stenosis) Study
Circulation, February 7, 2006; 113(5): 711 - 721.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
W. C. Roberts and J. M. Ko
Relation of weights of operatively excised stenotic aortic valves to preoperative transvalvular peak systolic pressure gradients and to calculated aortic valve areas
J. Am. Coll. Cardiol., November 2, 2004; 44(9): 1847 - 1855.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
G. P. Aurigemma and W. H. Gaasch
Low flow-low gradient aortic stenosis: The pathologist weighs in
J. Am. Coll. Cardiol., November 2, 2004; 44(9): 1856 - 1858.
[Full Text] [PDF]